Use of Traditional Chinese Medicine in Chinese Patients with Cancer Receiving Outpatient Care: Primary Rasons and Communication with Oncologists

Abstract

Background and objectives: Traditional Chinese medicine (TCM) is widely used in cancer care in China as an integral part of treatment. This study aimed to understand the motivations of cancer patients in China for adopting TCM in their treatment and to examine their communication with oncologists. Gaining insights into these factors can enhance culturally sensitive, patient-centered oncology care.

Methods: A consecutive sample of 287 outpatients with cancer was recruited. Sociodemographic and clinical data, TCM usage, primary reasons for adopting TCM, and communication about TCM with oncologists were collected. Descriptive statistics, binary logistic regression, and thematic analysis were used to analyze the data.

Results: Patients’ primary reasons for choosing TCM fell into five main categories: (1) belief in the benefits of TCM itself, (2) recommendations from others (family, friends, or oncologists), (3) belief in the benefits of combining TCM with Western medicine (WM), (4) previous positive experiences with TCM, and (5) dissatisfaction with or intolerance to WM. Among the 103 patients who consulted external TCM providers, 65% disclosed this to their oncologists. A longer time since diagnosis was associated with a higher likelihood of disclosure, while employed patients were less likely to inform their oncologists. Oncologists’ responses varied, with 55% neither approving nor disapproving of external TCM prescriptions.

Conclusions: The primary reasons for TCM use were perceived benefits and recommendations from oncologists and family members. However, communication about TCM with oncologists remains inconsistent. Enhancing patient-provider communication through education and fostering the integration of TCM and WM can improve holistic cancer care.

Keywords

Cancer / Traditional Chinese medicine / Communication / Cultural belief / Reasons for TCM adoption / Patient education

References

[1] Leng J, Lei L, Lei SF, Zhu Z, Ocampo A, Gany F. Use of Traditional Chinese Herbal Medicine Concurrently with Conventional Cancer Treatment Among Chinese Cancer Patients. J Immigr Minor Health 2020; 22(6):1240-1247. doi:10.1007/s10903-020-01017-2, PMID:32418000.

[2] So TH, Chan SK, Lee VH, Chen BZ, Kong FM, Lao LX. Chinese Medicine in Cancer Treatment - How is it Practised in the East and the West? Clin Oncol (R Coll Radiol) 2019; 31(8):578-588. doi:10.1016/j.clon.2019.05.016, PMID:31178347.

[3] Xiong SQ, Chen Y, Wang LJ, Lyu PP, Liao W, Wang C, et al. Usage of Chinese Herbs in Cancer Patients in Southern China: A Survey. Chin J Integr Med 2021; 27(7):502-508. doi:10.1007/s11655-019-3184-6, PMID:32388824.

[4] Matos LC, Machado JP, Monteiro FJ, Greten HJ. Understanding Traditional Chinese Medicine Therapeutics: An Overview of the Basics and Clinical Applications. Healthcare (Basel) 2021; 9(3):257. doi:10.3390/ healthcare9030257, PMID:33804485.

[5] Zhang X, Qiu H, Li C, Cai P, Qi F. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends 2021; 15(5):283-298. doi:10.5582/bst.2021.01318, PMID:34421064.

[6] Sun L, Mao JJ, Vertosick E, Seluzicki C, Yang Y. Evaluating Cancer Patients’ Expectations and Barriers Toward Traditional Chinese Medicine Utilization in China: A Patient-Support Group-Based Cross-Sectional Survey. Integr Cancer Ther 2018; 17(3):885-893. doi:10.1177/1534735418777117, PMID:29888609.

[7] Kuo YT, Chang TT, Muo CH, Wu MY, Sun MF, Yeh CC, et al. Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based Study. Integr Cancer Ther 2018; 17(2):531-541. doi:10.1177/1534735417716302, PMID:28665160.

[8] Dong X, Jiang J. Association Between Cancer and Utilization of Traditional Chinese Medicine in U.S. Chinese Women: Findings From the PINE Study. Gerontol Geriatr Med 2018; 4:2333721418778199. doi:10.1177/2333721418778199, PMID:30038950.

[9] Lu SY, Chen JJ, Pan JI, Fu ZX, Wu JL, Hsieh TC. The Association Between Different Patterns of Traditional Chinese Medicine Treatment and All-Cause Mortality Among Cancer Patients. Integr Cancer Ther 2019; 18:1534735418823273. doi:10.1177/153473541882 3273, PMID:30791738.

[10] Choi S, Karki Kunwor S, Im H, Choi D, Hwang J, Ahmed M, et al. Traditional and Complementary Medicine Use among Cancer Patients in Asian Countries: A Systematic Review and Meta-Analysis. Cancers (Basel) 2024; 16(18):3130. doi:10.3390/cancers16183130, PMID:39335102.

[11] Lee WQ, Teoh J, Lee PZK, Low ZXG, Sim X, Chong FFM, et al. Factors influencing communication of traditional Chinese medicine use between patients and doctors: A multisite cross-sectional study. J Integr Med 2019; 17(6):396-403. doi:10.1016/j.joim.2019.09.001, PMID:31548146.

[12] Collaço N, Lippiett KA, Wright D, Brodie H, Winter J, Richardson A, et al. Barriers and facilitators to integrated cancer care between primary and secondary care: a scoping review. Support Care Cancer 2024; 32(2):120. doi:10.1007/s00520-023-08278-1, PMID:38252169.

[13] Liu J, Sun Y, Liu S, He J. Belief in and Use of Traditional Chinese Medicine in Chinese Patients with Cancer Receiving Outpatient Care. Eur J Integr Med 2023;58:102221. doi:10.1016/j.eujim.2022.102221.

[14] Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl) 2022; 135(5):584-590. doi:10.1097/ CM9.0000000000002108, PMID:35143424.

[15] Myerson R, Lu T, Yuan Y, Liu GG. Cancer diagnosis and care among rural- to-urban migrants in China. BMJ Glob Health 2019; 4(6):e001923. doi:10.1136/bmjgh-2019-001923, PMID:31908866.

[16] Zhang X, Guo Q, Li C, Liu R, Xu T, Jin Z, et al. Immortal Time Bias- Corrected Effectiveness of Traditional Chinese Medicine in Non-Small Cell Lung Cancer (C-EVID): A Prospective Cohort Study. Front Oncol 2022;12:845613. doi:10.3389/fonc.2022.845613, PMID:35530347.

[17] Bai X, Ta N, Gong GH, Zhang B, Wei CX. Effects of Integrated Chinese Traditional Medicine and Conventional Western Medicine on the Quality of Life of Breast Cancer Patients: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2022; 2022:3123878. doi:10.1155/2022/3123878, PMID:35035500.

[18] Jin YH, Wang YP, Xie YL, Tian GH, Zhang XY, Shi NN, et al. Research on the development methodology for clinical practice guidelines for organic integration of traditional Chinese and Western medicine. Mil Med Res 2023; 10(1):45. doi:10.1186/s40779-023-00481-9, PMID:37752599.

[19] Liao X, Bu Y, Jia Q. Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future. Genes Dis 2020; 7(3):370-379. doi:10.1016/j.gendis.2019.10.016, PMID:32884991.

[20] Yang Y, Qu T, Yang J, Ma B, Leng A. Confucian Familism and Shared Decision Making in End-of-Life Care for Patients with Advanced Cancers. Int J Environ Res Public Health 2022; 19(16):10071. doi:10.3390/ ijerph191610071, PMID:36011706.

[21] Zhai H, Lavender C, Li C, Wu H, Gong N, Cheng Y. Who decides? Shared decision-making among colorectal cancer surgery patients in China. Support Care Cancer 2020; 28(11):5353-5361. doi:10.1007/ s00520-020-05391-3, PMID:32133543.

[22] Bazrafshani MS, Pardakhty A, Kalantari Khandani B, Tajadini H, Ghazanfari Pour S, Hashemi S, et al. The prevalence and predictors of herb-drug interactions among Iranian cancer patients during chemotherapy courses. BMC Complement Med Ther 2023; 23(1):41. doi:10.1186/s12906-023-03869-1, PMID:36750849.

[23] Ziemann J, Lendeckel A, Müller S, Horneber M, Ritter CA. Herb-drug interactions: a novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatment. Eur J Clin Pharmacol 2019; 75(9):1237-1248. doi:10.1007/ s00228-019-02700-6, PMID:31154477.

[24] Yang G, Zhang H, Gan Z, Fan Y, Gu W, Ling C. Discrepant Views of Oncologists and Cancer Patients on Complementary and Alternative Medicine in a Chinese General Hospital. Integr Cancer Ther 2018; 17(2):451-457. doi:10.1177/1534735417725579, PMID:28870099.